abstract |
The invention relates to compounds of formulas @@ and their pharmaceutically acceptable salts and hydrates, the substituents of X1, R1, R2 and R11 being defined in the description. The invention also relates to pharmaceutical compositions containing said compounds and methods of treating hyperproliferative disorders in mammals by administering said compounds. |